SCHEMBL19081874

SCHEMBL19081874

c1ccc(-c2ccc3cc(-c4c5ccccc5c(-c5ccc6oc7c(ccc8c9ccccc9sc87)c6c5)c5ccccc45)ccc3c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 4/20 0.38
PGR P06401 1/20 0.36
LIMK1 P53667 2/20 0.36
PLA2G2A P14555 3/20 0.36
PLA2G4A P47712 3/20 0.36
ESR1 P03372 3/20 0.34
TNKS O95271 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
ALOX5 P09917 1/20 0.33
PIM3 Q86V86 2/20 0.33
PIM1 P11309 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
PRKDC P78527 1/20 0.32
PLA2G10 O15496 1/20 0.32
GPR84 Q9NQS5 1/20 0.32
PTPRF P10586 2/20 0.32
PTPN2 P17706 2/20 0.32
PTPN1 P18031 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17944801 0.94 ESR2 (0.37) ESR2PGRLIMK1PLA2G2APLA2G4A
SCHEMBL17944365 0.93 ESR2 (0.41) ESR2LIMK1PLA2G2APLA2G4AESR1
SCHEMBL18268559 0.93 ESR2 (0.41) ESR2LIMK1PLA2G2APLA2G4AESR1
SCHEMBL19108891 0.88 PLA2G2A (0.38) ESR2LIMK1PLA2G2APLA2G4AESR1
SCHEMBL19108846 0.88 CYP1A1 (0.39) ESR2ESR1ALOX5PRKDCGPR84
SCHEMBL24341015 0.88 LIMK1 (0.36) ESR2PGRLIMK1PLA2G2APLA2G4A
SCHEMBL17944808 0.86 ESR2 (0.40) ESR2ESR1ALOX5PRKDCS1PR4
SCHEMBL19108933 0.86 LIMK1 (0.36) ESR2PGRLIMK1PLA2G2APLA2G4A
SCHEMBL24341308 0.86 ESR2 (0.36) ESR2LIMK1PLA2G2APLA2G4AESR1
SCHEMBL19076905 0.86 ESR2 (0.37) ESR2ESR1ALOX5PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ESR2 542/4885PGR 1721/4885LIMK1 440/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ESR2 542/4885PGR 1721/4885LIMK1 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.